---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-177651"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:25:43.752388+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines stockholders elect directors, ratify auditor, approve say-on-pay at annual meeting

## Summary
- Elected three Class II directors: Sushil Patel, Eric Schmidt, Thilo Schroeder with substantial support.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 (62.1M for, 6,377 against).
- Advisory approval of named executive officer compensation (53.4M for, 4.6M against, broker non-votes 4.1M).
- Advisory vote favored holding future say-on-pay votes annually (57.8M for one year); company will adopt annual frequency.

## SEC filing metadata
- accession: 0001193125-22-177651
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312522177651/0001193125-22-177651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312522177651/d370111d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-177651
- JSON: https://secwatch.observer/filing/0001193125-22-177651.json
- Plain text: https://secwatch.observer/filing/0001193125-22-177651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.